Cancer immunotherapy.

  title={Cancer immunotherapy.},
  author={Steven A Rosenberg and Mark Edward Dudley and Nicholas P Restifo},
  journal={The New England journal of medicine},
  volume={359 10},
To the Editor: In his review of cancer immunology, Finn (June 19 issue)1 states that the results of immunotherapy involving intravenous administration of tumor-specific autologous T cells (adoptive cell therapy) are “marginal,” whereas the results of trials of cancer vaccines are “encouraging.” We do not believe this conclusion accurately reflects the state of the field. In 1994, we reported a 34% objective response rate among patients with metastatic melanoma who were treated with adoptive… CONTINUE READING

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-10 of 20 extracted citations

Survivin-Based Treatment Strategies for Squamous Cell Carcinoma

International journal of molecular sciences • 2018
View 7 Excerpts
Highly Influenced

Defective HLA class I antigen processing machinery in cancer

Cancer Immunology, Immunotherapy • 2018
View 1 Excerpt

Similar Papers

Loading similar papers…